Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

The use of the dog electroencephalogram (EEG) in safety pharmacology to evaluate proconvulsant risk.

The use of the dog electroencephalogram (EEG) in safety pharmacology to evaluate proconvulsant risk. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • The use of the dog electroencephalogram (EEG) in safety pharmacology to evaluate proconvulsant risk. Abstract Text:

    niklaus Niklaus ,philippe guillaumePhilippe Guillaume,pierre lacroixPierre Lacroix,roger d porsoltRoger D Porsolt,paul moserPaul Moser,

    INTRODUCTION: The dog is frequently used for cardiovascular safety pharmacology and for toxicology studies, but is not often used for central nervous system (CNS) safety pharmacology purposes. We have therefore examined the electroencephalogram (EEG) in conscious dogs by means of radio-telemetry methods using the proconvulsant agent pentylenetetrazole (PTZ) as reference substance. Assessment of proconvulsant risk is an important aspect of CNS safety evaluation and the EEG is a sensitive technique for identifying pathologic brain activity, most importantly paroxysmal activity. METHODS: Dogs were implanted with epidural electrodes wired to subcutaneously placed radiotransmitters. Following baseline recording, the test substance was administered and the EEG and electromyogram (EMG) activities were recorded from dogs placed in slings. The EEG was assessed visually for abnormal activity and dogs were also continuously observed for the appearance of overt convulsive activity. The PTZ infusion was stopped and diazepam was administered as soon as clear and sustained EEG effects and/or behavioural symptoms occurred. RESULTS: Slow i.v. infusion of PTZ (1.5 mg/kg/min) induced clear paroxysmal effects on the EEG trace in the form of spike and wave trains of 4-5 Hz. Paroxysmal activity associated with clonic convulsions occurred between 17 and 36 min after the start of infusion (a mean of 24 min) but in most cases paroxysmal activity was observed approximately 60 s prior to any overt convulsive activity. DISCUSSION: These data show the usefulness of the telemetered dog EEG in safety pharmacology. The dog EEG is appropriate in situations where results from cardiovascular and CNS safety tests in the same species are required, or where the use of other species is contraindicated because of metabolic or pharmacokinetic particularities.

    The use of the dog electroencephalogram (EEG) in safety pharmacology to evaluate proconvulsant risk. Publishing Authors By Initials

    n N ,p guillaumeP Guillaume,p lacroixP Lacroix,rd porsoltRD Porsolt,p moserP Moser,

    For similar abstracts research abstracts see: abstracts research

    PUBMED ID PMID:

    MEDLINE DATE: 2007 Sep-Oct

    The use of the dog electroencephalogram (EEG) in safety pharmacology to evaluate proconvulsant risk. Journal Published:

    PUBLICATION TYPE: Journal Article

    Journal: Journal of pharmacological and toxicological metho

    VOLUME: 56

    Page Numbers: 234-8

    Journal Abbreviation:

    ISSN: 1056-8719

    DAY: 24

    MONTH: 05

    YEAR: 2007

    The use of the dog electroencephalogram (EEG) in safety pharmacology to evaluate proconvulsant risk. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 9206091

    The use of the dog electroencephalogram (EEG) in safety pharmacology to evaluate proconvulsant risk. Keywords Mesh Terms:

    KEYWORDS:

    MESH TERMS:

    Chemical & Substance for Abstract: The use of the dog electroencephalogram (EEG) in safety pharmacology to evaluate proconvulsant risk. Information

    Substance Name:

    Registry Number:

    Grant and Affiliation Information for The use of the dog electroencephalogram (EEG) in safety pharmacology to evaluate proconvulsant risk.

    AFFILIATION: Porsolt and Partners Pharmacology, 9bis rue Henri Martin, 92100 Boulogne-Billancourt, France. ndurmuller@porsolt.com

    Country: United States

    United States Research PublicationUnited States Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: J Pharmacol Toxicol Methods

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    The use of the dog electroencephalogram EEG in safety pharmacology to evaluate proconvulsant risk Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News